These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19451502)

  • 21. A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours.
    Baruchel S; Sharp JR; Bartels U; Hukin J; Odame I; Portwine C; Strother D; Fryer C; Halton J; Egorin MJ; Reis RM; Martinho O; Stempak D; Hawkins C; Gammon J; Bouffet E
    Eur J Cancer; 2009 Sep; 45(13):2352-9. PubMed ID: 19505817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rosai-Dorfman disease with orbital and rhinopharyngeal localizations. A case report].
    Ben Ghorbel I; Bouzaidi K; Chelaifa K; Kchir MN; Khanfir M; Trabelsi S; Lamloum M; Houman MH; Miled M
    Ann Otolaryngol Chir Cervicofac; 2003 Nov; 120(5):308-12. PubMed ID: 14726851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosai-Dorfman disease presenting as a solitary mediastinal mass.
    Hida AI; Yagi S; Obase Y; Nishimura H; Akiyama T; Irei I; Hamazaki S; Oka M; Sadahira Y
    Pathol Int; 2009 Apr; 59(4):265-8. PubMed ID: 19351372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of Rosai-Dorfman disease with low-dose oral corticosteroid.
    Oka M; Kamo T; Goto N; Nagano T; Hirayama Y; Nibu K; Nishigori C
    J Dermatol; 2009 Apr; 36(4):237-40. PubMed ID: 19348664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosai-Dorfman disease of the breast mimicking cancer.
    da Silva BB; Lopes-Costa PV; Pires CG; Moura CS; Borges RS; da Silva RG
    Pathol Res Pract; 2007; 203(10):741-4. PubMed ID: 17673371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous Rosai-Dorfman disease presenting as a granulomatous rosacea-like rashs.
    Shi XY; Ma DL; Fang K
    Chin Med J (Engl); 2011 Mar; 124(5):793-4. PubMed ID: 21518580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report of two cases of Rosai-Dorfman disease with only skin involvement.
    Mourmouras V; Falzarano SM; Miracco C
    Pathologica; 2008 Oct; 100(5):414-5. PubMed ID: 19253603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium.
    Geoerger B; Morland B; Ndiaye A; Doz F; Kalifa G; Geoffray A; Pichon F; Frappaz D; Chatelut E; Opolon P; Hain S; Boderet F; Bosq J; Emile JF; Le Deley MC; Capdeville R; Vassal G;
    Eur J Cancer; 2009 Sep; 45(13):2342-51. PubMed ID: 19362466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine-needle aspiration cytology of Rosai-Dorfman disease of bone.
    Jing X; McHugh JB; Pu RT
    Diagn Cytopathol; 2008 Jul; 36(7):516-8. PubMed ID: 18528889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine.
    Tasso M; Esquembre C; Blanco E; Moscardó C; Niveiro M; Payá A
    Pediatr Blood Cancer; 2006 Oct; 47(5):612-5. PubMed ID: 16302214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rosai-Dorfman disease presenting as an isolated extranodal mass of the carotid sheath: a case report.
    Lee L; Glastonbury CM; Lin D
    Ear Nose Throat J; 2007 Oct; 86(10):624-7. PubMed ID: 17990686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib mesylate responsiveness in aggressive systemic mastocytosis: novel association with a platelet derived growth factor receptor beta mutation.
    Dalal BI; Horsman DE; Bruyèrè H; Forrest DL
    Am J Hematol; 2007 Jan; 82(1):77-9. PubMed ID: 17133421
    [No Abstract]   [Full Text] [Related]  

  • 34. Rosai-Dorfman disease successfully treated with thalidomide: A case report.
    Shahidi-Dadras M; Hamedani B; Niknezhad N; Ghilizadeh N
    Dermatol Ther; 2019 Sep; 32(5):e13005. PubMed ID: 31228316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous Rosai-Dorfman disease of the forearm: case report.
    Potts CA; Bozeman AP; Walker AN; Floyd WE
    J Hand Surg Am; 2008 Oct; 33(8):1409-13. PubMed ID: 18929211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study.
    Soria A; Cario-André M; Lepreux S; Rezvani HR; Pasquet JM; Pain C; Schaeverbeke T; Mahon FX; Taïeb A
    Dermatology; 2008; 216(2):109-17. PubMed ID: 18216472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracranial dural histiocytosis.
    Russo N; Giangaspero F; Beccaglia MR; Santoro A
    Br J Neurosurg; 2009 Aug; 23(4):449-54. PubMed ID: 19637021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous Rosai - Dorfman disease in a patient with late syphilis and cervical cancer - case report and a review of literature.
    Bielach-Bazyluk A; Serwin AB; Pilaszewicz-Puza A; Flisiak I
    BMC Dermatol; 2020 Dec; 20(1):19. PubMed ID: 33287799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of sclerodermatous graft-versus-host disease responsive to imatinib therapy.
    Lazar J; Poonawalla T; Teng JM
    Pediatr Dermatol; 2011; 28(2):172-5. PubMed ID: 21504445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dapsone as a potential treatment for cutaneous Rosai-Dorfman disease with neutrophilic predominance.
    Chan CC; Chu CY
    Arch Dermatol; 2006 Apr; 142(4):428-30. PubMed ID: 16618860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.